Search

Displaying 1 - 17 of 17 items.

Clomiphene Citrate

Clomiphene citrate, more commonly known by its brand names Clomid and Serophene, is a medication prescribed to women to stimulate ovulation in order to treat infertility. It stimulates ovulation in women who do not ovulate or ovulate irregularly. This drug was created by Dr. Frank Palopoli in 1956 while he worked for Merrell Company. It first successfully induced ovulation in women in 1961 and was approved by the Federal and Drug Administration (FDA) in 1967.

Format: Articles

Subject: Technologies

Progestin: Synthetic Progesterone

Progestin is a synthetic form of progesterone, a naturally occurring hormone, which plays an important role in the female reproductive cycle. During the 1950s two types of progestin that were later used in birth control pills were created, norethindrone and norethynodrel. In 1951 Carl Djerassi developed norethindrone at Syntex, S.A. laboratories located in Mexico City, receiving a patent on 1 May 1956. In 1953 Frank Colton developed norethynodrel at G.D. Searle and Company laboratories located in Chicago, receiving a patent on 29 November 1955.

Format: Articles

Subject: Technologies, Reproduction

The Development of Silicone Breast Implants for Use in Breast Augmentation Surgeries in the United States

In the 1960s, two plastic surgeons from the United States, Thomas Dillon Cronin and Frank Judson Gerow, collaborated with the Dow Corning Corporation, which specialized in silicone products, to create the first silicone breast implant. Surgeons used the implant, named the Cronin-Gerow implant, to improve the look of a woman’s breasts, by correcting for asymmetry, augmenting the size, or creating a more uplifted profile.

Format: Articles

Subject: Technologies, Processes

Green Fluorescent Protein

Green fluorescent protein (GFP) is a protein in the jellyfish Aequorea Victoria that exhibits green fluorescence when exposed to light. The protein has 238 amino acids, three of them (Numbers 65 to 67) form a structure that emits visible green fluorescent light. In the jellyfish, GFP interacts with another protein, called aequorin, which emits blue light when added with calcium. Biologists use GFP to study cells in embryos and fetuses during developmental processes.

Format: Articles

Subject: Technologies

Enovid: The First Hormonal Birth Control Pill

Enovid was the first hormonal birth control pill. G. D. Searle and Company began marketing Enovid as a contraceptive in 1960. The technology was created by the joint efforts of many individuals and organizations, including Margaret Sanger, Katharine McCormick, Gregory Pincus, John Rock, Syntex, S.A. Laboratories, and G.D. Searle and Company Laboratories.

Format: Articles

Subject: Technologies, Reproduction

Plan B: Emergency Contraceptive Pill

Plan B is a progestin-only emergency contraceptive pill (ECP) that can be taken within seventy-two hours of unprotected sex in order to prevent an unwanted pregnancy. Plan B was created in response to the United States Food and Drug Administration's (US FDA) 1997 request for new drug applications (NDAs) for a dedicated ECP product, and was approved for sales in the US in 1999. Duramed, a subsidiary of Barr Pharmaceuticals, manufactures Plan B for The Women's Capital Corporation (WCC), which owns the patent for Plan B.

Format: Articles

Subject: Technologies, Reproduction

The Measles, Mumps, and Rubella (MMR) Vaccine

The measles, mumps, and rubella (MMR) vaccine was created by Maurice Hilleman in 1971 at the Merck Institute of Therapeutic Research, a pharmaceutical company in West Point, Pennsylvania. It combined three separate vaccines for measles, mumps, and rubella, common and sometimes fatal diseases. Measles causes a red skin rash and severe fevers that can be fatal. Mumps causes fever and swelling of the salivary glands in the mouth and jaw, while rubella causes milder fevers and skin rashes.

Format: Articles

Subject: Technologies

Gamete Intra-Fallopian Transfer (GIFT)

Various techniques constitute assisted reproduction, one of which is gamete intra-fallopian transfer (GIFT). The first example of GIFT involved primates during the 1970s; however, the technology was unsuccessful until 1984 when an effective GIFT method was invented by Ricardo Asch at the University of Texas Health Sciences Center and the procedure resulted in the first human pregnancy. The GIFT technique was created in hopes of generating an artificial insemination process that mimicked the physiological sequences of normal conception.

Format: Articles

Subject: Technologies, Reproduction

Breast Augmentation Techniques

Breast augmentation involves the use of implants or fat tissue to increase patient breast size. As of 2019, breast augmentation is the most popular surgical cosmetic procedure in the United States, with annual patient numbers increasing by 41 percent since the year 2000. Since the first documented breast augmentation by surgeon Vincenz Czerny in 1895, and later the invention of the silicone breast implant in 1963, surgeons have developed the procedure into its own specialized field of surgery, creating various operating techniques for different results.

Format: Articles

Subject: Technologies, Processes, Reproduction, Ethics

Stanley Paul Leibo (1937–2014)

Stanley Paul Leibo studied the cryopreservation of embryos in the US in the twentieth century. Cryopreservation is a method of preserving biological material through freezing. Early in his career, Leibo collaborated with other scientists to study why cells were oftentimes injured during freezing. Later, Leibo and his team accomplished one of the first successful births using previously-frozen mammalian embryos.

Format: Articles

Subject: People, Technologies

Shoukhrat Mitalipov and Masahito Tachibana's Mitochondrial Gene Replacement Therapy Technique

In 2009, Shoukhrat Mitalipov, Masahito Tachibana, and their team of researchers developed the technology of mitochondrial gene replacement therapy to prevent the transmission of a mitochondrial disease from mother to offspring in primates. Mitochondria contain some of the body's genetic material, called mitochondrial DNA. Occasionally, the mitochondrial DNA possesses mutations.

Format: Articles

Subject: Technologies

ABO Blood Type Identification and Forensic Science (1900-1960)

The use of blood in forensic analysis is a method for identifying individuals suspected of committing some kinds of crimes. Paul Uhlenhuth and Karl Landsteiner, two scientists working separately in Germany in the early twentieth century, showed that there are differences in blood between individuals. Uhlenhuth developed a technique to identify the existence of antibodies, and Landsteiner and his students showed that humans had distinctly different blood types called A, B, AB, and O.

Format: Articles

Subject: Theories, Legal, Technologies

Ooplasmic Transfer Technology

Ooplasmic transfer, also called cytoplasmic transfer, is an outside the body, in vitro fertilization (IVF) technique. Ooplasmic transfer in humans (Homo sapiens) is similar to in vitro fertilization (IVF), with a few additions. IVF is the process in which doctors manually combine an egg and sperm cells in a laboratory dish, as opposed to artificial insemination, which takes place in the female's body. For ooplasmic transfer, doctors withdraw cytoplasm from a donor's oocyte, and then they inject that cytoplasm with sperm into a patient's oocyte.

Format: Articles

Subject: Technologies

Edwin Carlyle (Carl) Wood (1929–2011)

Edwin Carlyle Wood, also known as Carl Wood, was a physician who helped develop in vitro fertilization, or IVF, treatments. From 1964 to 1992, Wood worked as a professor of obstetrics and gynecology at Monash University in Melbourne, Australia, where he was one of the first in the world to lead a team of physicians to establish IVF as a proven treatment for infertility. IVF refers to a medical procedure in which scientists inseminate an egg cell with a sperm cell outside of the body, such as in a glass dish in a clinical setting.

Format: Articles

Subject: People, Technologies, Reproduction

Kangaroo Mother Care

Physician researchers Edgar Rey Sanabria and Héctor Martínez-Gómez developed the Kangaroo Mother Program in Bogotá, Colombia, in 1979, as an alternative to conventional incubator treatment for low birth weight infants. As of 2018, low birth weight and its associated complications are the leading causes of infant death, especially in developing and underdeveloped countries where access to technology and skilled healthcare providers is limited. Kangaroo Mother Care is a simple and low cost method for treating low birth weight infants.

Format: Articles

Subject: Technologies

Menstrual Tampon

Menstrual tampons are feminine hygiene devices, usually made of absorbent cotton, that are temporarily inserted into the vagina for absorbing a woman’s blood during menstruation. In 1931, Earl Haas invented the menstrual tampon most commonly used in the twenty-first century. Later, Gertrude Tendrich produced the first commercial tampon brand, Tampax, using Haas’s patented design. Tendrich and Haas’s tampon was made of tightly compacted absorbent cotton, shaped like a bullet, and had a string attached at the base that allowed for easy removal from the woman’s body.

Format: Articles

Subject: Technologies

George McDonald Church (1954- )

George McDonald Church studied DNA from living and from extinct species in the US during the twentieth and twenty-first centuries. Church helped to develop and refine techniques with which to describe the complete sequence of all the DNA nucleotides in an organism's genome, techniques such as multiplex sequencing, polony sequencing, and nanopore sequencing. Church also contributed to the Human Genome Project, and in 2005 he helped start a company, the Personal Genome Project. Church proposed to use DNA from extinct species to clone and breed new organisms from those species.

Format: Articles

Subject: People, Technologies